Skip to content

ASAPHARM

Active
Private limited companyfounded 201610 yrs activeRue du Petit-Leez, Gd-L. 42, 5031 Gembloux, BelgiumKBO/BCE: BE 0645.733.354
Summary

ASAPHARM has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €160,138 and a net result of €139,678. Equity is growing by ~18% per year across the filed fiscal years. Its solvency ranks better than 19% of 10519 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability59▼-3
Solvency34▼-10
Growth78=
Track record100
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €8,000 at 30 days acceptable
Liquidity short (current ratio 0.05 against 0.35 in 2024; short-term debt: 28.7% and cash: 0.4% of total assets), and 91.4% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
8.6%
Return on assets
7.5%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 10519 sector peers (2025).
NBB · sector comparison
Position among 10519 sector peers
Solvency
better than 19%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
32 d early
2024
20 d early
2023
13 d early
2022
33 d early
2021
11 d early
2020
26 d late
2019
45 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 5 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 8 January 2016, ASAPHARM was incorporated.1 Total assets went from EUR 76,281 in 2018 to EUR 1.9 million in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€139,678▲ 14.4%
2024 · €122,045
Working capital
-€508,173▼ 296%
2024 · -€128,421
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€17,105▼ 32.1%€6,282▼ 63.3%€34,888▲ 455%€43,834▲ 25.6%€83,048▲ 89.5%
Net result€10,881within the sector's middle half▼ 42.0%-€7,166below the sector's middle half€108,722within the sector's middle half€122,045within the sector's middle half▲ 12.3%€139,678above the sector's middle half▲ 14.4%
Equity€93,946within the sector's middle half▲ 13.1%€45,603within the sector's middle half▼ 51.5%€130,325within the sector's middle half▲ 186%€252,370within the sector's middle half▲ 93.6%€160,138within the sector's middle half▼ 36.5%
Total assets€144,351within the sector's middle half▲ 57.2%€1.3mabove the sector's middle half▲ 769%€1.3mwithin the sector's middle half▲ 1.9%€1.3mwithin the sector's middle half▲ 1.9%€1.9mabove the sector's middle half▲ 42.8%
Debt€50,406▲ 474%€1.2m▲ 2,298%€1.1m▼ 5.0%€1.1m▼ 8.5%€1.7m▲ 61.9%
Working capital€92,127above the sector's middle half▲ 14.2%-€127,641below the sector's middle half-€173,048below the sector's middle half▼ 35.6%-€128,421below the sector's middle half▲ 25.8%-€508,173below the sector's middle half▼ 296%
Solvency65.1%above the sector's middle half▼ 25.4pp3.6%below the sector's middle half▼ 61.4pp10.2%below the sector's middle half▲ 6.6pp19.4%within the sector's middle half▲ 9.2pp8.6%below the sector's middle half▼ 10.8pp
Current ratio2.83above the sector's middle half▼ 7.360.29below the sector's middle half▼ 2.540.17below the sector's middle half▼ 0.120.35below the sector's middle half▲ 0.180.05below the sector's middle half▼ 0.30
Return on assets (ROA)7.5%within the sector's middle half▼ 12.9pp-0.6%within the sector's middle half▼ 8.1pp8.5%within the sector's middle half▲ 9.1pp9.4%within the sector's middle half▲ 0.9pp7.5%within the sector's middle half▼ 1.9pp
Staff (FTE)0below the sector's middle half0below the sector's middle half
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
-€50,000€0€50,000€100,000€150,000Operating result 2021: €17,105€17,105Net result 2021: €10,881€10,881Operating result 2022: €6,282€6,282Net result 2022: -€7,166-€7,166Operating result 2023: €34,888€34,888Net result 2023: €108,722€108,722Operating result 2024: €43,834€43,834Net result 2024: €122,045€122,045Operating result 2025: €83,048€83,048Net result 2025: €139,678€139,67820212022202320242025€0€50,000€100,000€150,000Operating result 2023: €34,888€34,900Net result 2023: €108,722€109,000Operating result 2024: €43,834€43,800Net result 2024: €122,045€122,000Operating result 2025: €83,048€83,000Net result 2025: €139,678€140,000202320242025
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 89% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.9m
Fixed assets €1.8m ▲ 48.6%
Current assets €26,557 ▼ 61.1%
Equity and liabilities €1.9m
Equity €160,138 ▼ 36.5%
Debt €1.7m ▲ 61.9%
Debt's share of the balance-sheet total rises from 80.6% to 91.4%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€94,549▲
2024 · €52,692
Cash flow
€151,178▲
2024 · €130,903
Debt to equity
10.62▲
2024 · 4.16
ROE
87.2%▲
2024 · 48.4%
Interest coverage
3.71▼
2024 · 3.74
Debt ≤ 1 year
€534,729▲
2024 · €196,681
Debt > 1 year
€1.2m▲
2024 · €849,913
Income taxes
€17,898▲
2024 · €7,705
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.3m€1.9m▲
Fixed assets21/28€1.2m€1.8m▲
Tangible fixed assets22/27€324,548€331,368▲
Land and buildings22€324,548€316,064▼
Furniture and vehicles24€0€15,304▲
Financial fixed assets28€910,000€1.5m▲
Current assets29/58€68,260€26,557▼
Amounts receivable within one year40/41€686€17,903▲
Trade receivables40€372€17,878▲
Other amounts receivable41€314€25▼
Cash at bank and in hand54/58€65,868€6,694▼
Deferred charges and accrued income490/1€1,706€1,960▲
Equity and liabilities
Total equity and liabilities10/49€1.3m€1.9m▲
Equity10/15€252,370€160,138▼
Contributions10/11€18,600€18,600=
Reserves13€1,860€1,860=
Distributable reserves133€1,860€1,860=
Profit (loss) carried forward14€231,910€139,678▼
Amounts payable17/49€1.1m€1.7m▲
Amounts payable after more than one year17€849,913€1.2m▲
Financial debts170/4€849,913€1.2m▲
Amounts payable within one year42/48€196,681€534,729▲
Current portion of amounts payable after more than one year42€90,119€136,408▲
Trade debts44€420€5,427▲
Suppliers440/4€420€5,427▲
Taxes, remuneration and social security45€6,626€13,202▲
Taxes450/3€6,626€13,202▲
Other amounts payable47/48€99,515€379,692▲
Accrued charges and deferred income492/3€3,844€4,598▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8,858€11,500▲
Other operating charges640/8€2,573€2,557▼
Gross operating margin9900€55,265€97,106▲
Operating profit (loss)9901€43,834€83,048▲
Financial income75/76B€100,000€100,000=
Recurring financial income75€100,000€100,000=
Financial charges65/66B€14,084€25,472▲
Recurring financial charges65€14,084€25,472▲
Profit (loss) for the period before taxes9903€129,750€157,576▲
Income taxes67/77€7,705€17,898▲
Profit (loss) for the period9904€122,045€139,678▲
Profit (loss) for the period to be appropriated9905€122,045€139,678▲
Appropriation of the result
Profit (loss) to be appropriated9906€231,910€371,588▲
Profit (loss) brought forward from the previous period14P€109,865€231,910▲
Profit to be distributed694/7€0€231,910▲
Return on contributions (dividend)694€0€231,910▲
Social balance
Average headcount (FTE)90870.00.0=

The notes to these accounts (18 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,045€53,047€9,115€8,858€11,500▲ 29.8%
Other operating charges640/8€430€2,702€2,296€2,573€2,557▼ 0.6%
Gross operating margin9900€18,580€62,031€46,299€55,265€97,106▲ 75.7%
Operating profit (loss)9901€17,105€6,282€34,888€43,834€83,048▲ 89.5%
Financial income75/76B€112-€92,000€100,000€100,000=
Recurring financial income75€112-€92,000€100,000€100,000=
Financial charges65/66B€823€13,013€11,636€14,084€25,472▲ 80.9%
Recurring financial charges65€823€13,013€11,636€14,084€25,472▲ 80.9%
Profit (loss) for the period before taxes9903€16,395-€6,731€115,252€129,750€157,576▲ 21.4%
Income taxes67/77€5,513€435€6,530€7,705€17,898▲ 132%
Profit (loss) for the period9904€10,881-€7,166€108,722€122,045€139,678▲ 14.4%
Profit (loss) for the period to be appropriated9905€10,881-€7,166€108,722€122,045€139,678▲ 14.4%
Line20212022202320242025Change
Assets
Total assets20/58€144,351€1.3m€1.3m€1.3m€1.9m▲ 42.8%
Fixed assets21/28€1,819€1.2m€1.2m€1.2m€1.8m▲ 48.6%
Tangible fixed assets22/27€1,819€342,522€333,406€324,548€331,368▲ 2.1%
Land and buildings22-€341,516€333,032€324,548€316,064▼ 2.6%
Furniture and vehicles24€1,819€1,006€374€0€15,304-
Financial fixed assets28-€860,000€910,000€910,000€1.5m▲ 65.2%
Current assets29/58€142,532€51,775€34,975€68,260€26,557▼ 61.1%
Amounts receivable within one year40/41€126,405€32,217€14,698€686€17,903▲ 2,510%
Trade receivables40€125,916€15,755€8,223€372€17,878▲ 4,707%
Other amounts receivable41€489€16,462€6,475€314€25▼ 92.0%
Cash at bank and in hand54/58€15,480€18,862€19,148€65,868€6,694▼ 89.8%
Deferred charges and accrued income490/1€648€696€1,130€1,706€1,960▲ 14.9%
Equity and liabilities
Total equity and liabilities10/49€144,351€1.3m€1.3m€1.3m€1.9m▲ 42.8%
Equity10/15€93,946€45,603€130,325€252,370€160,138▼ 36.5%
Contributions10/11€18,600€18,600€18,600€18,600€18,600=
Reserves13€1,860€1,860€1,860€1,860€1,860=
Non-distributable reserves130/1€1,860-----
Reserves not available under the articles1311€1,860-----
Distributable reserves133-€1,860€1,860€1,860€1,860=
Profit (loss) carried forward14€73,486€25,143€109,865€231,910€139,678▼ 39.8%
Amounts payable17/49€50,406€1.2m€1.1m€1.1m€1.7m▲ 61.9%
Amounts payable after more than one year17-€1.0m€940,032€849,913€1.2m▲ 36.6%
Financial debts170/4-€1.0m€940,032€849,913€1.2m▲ 36.6%
Amounts payable within one year42/48€50,406€179,416€208,024€196,681€534,729▲ 172%
Current portion of amounts payable after more than one year42-€88,433€89,245€90,119€136,408▲ 51.4%
Trade debts44€5,904€187€12,026€420€5,427▲ 1,193%
Suppliers440/4€5,904€187€12,026€420€5,427▲ 1,193%
Taxes, remuneration and social security45€2,140€9,778€5,903€6,626€13,202▲ 99.2%
Taxes450/3€2,140€8,278€5,903€6,626€13,202▲ 99.2%
Remuneration and social security454/9-€1,500----
Other amounts payable47/48€42,362€81,018€100,850€99,515€379,692▲ 282%
Accrued charges and deferred income492/3---€3,844€4,598▲ 19.6%
Line20212022202320242025Change
Profit (loss) for the period9904€10,881-€7,166€108,722€122,045€139,678▲ 14.4%
+ Depreciation and write-downs630€1,045€53,047€9,115€8,858€11,500▲ 29.8%
Operating cash flow (approximation)€11,926€45,881€117,838€130,903€151,178▲ 15.5%
Investment in fixed assets (approximation)--€1.3m-€50,000€0-€611,256-
Change in cash-€3,382€286€46,721-€59,175▼ 227%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
29-06
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial Highest result since 2018net €139,678 ▲14.4%
Operating result €83,048, net result €139,678, both a record.
11-07
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial Equity above €200,000Eq €252,370 ▲93.6%
2 profitable years in a row build equity to €252,370.
18-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial Back to profitnet €108,722
Net result €108,722 after one loss-making year.
31-12
Financial Equity above €100,000Eq €130,325 ▲186%
Equity rises from €45,603 to €130,325.
28-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Weakest financial yearnet -€7,166
Net result drops to -€7,166, the lowest in the series; recovery starts the following year.
20-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
26-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 26 days late
2020
31-12
Financial Liquidity triplescurrent ratio 10.19
Current ratio from 2.97 to 10.19; short-term debt falls from €28,875 to €8,780.
Show earlier events
14-09
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 45 days late
2019
31-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
02-07
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
27-06
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts

We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gembloux · 1 establishment unit since 2016
seat establishment The establishment unit on the map
Ground area
850 m²
Building footprint
125 m²
Parcel 92056E0551/00N000, Wallonia. Linked by address, not a title deed.
1 establishment unit
Rue du Petit-Leez, Gd-L. 42, 5031 Gembloux
Retail trade
since 20162.249.679.626
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
92056E0551/00N000 Wallonia 850 m² 1 · 125 m² -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

2 holdings

Owners 0

The accounts to 31-12-2025 list no shareholders, and no other source names one.

Holdings 2

According to the 2025 annual accounts of ASAPHARM and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,568 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded08-01-2016
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0645733354
Also 9925:BE0645733354
Registered 12-09-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.